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INTRODUCTION
Tumor-infiltrating lymphocytes (TILs) can be found in
most cancers with a variable intensity. They are mainly com-
posed of CD8+ cytotoxic T-cells, CD4+ helper T-cells and
NK cells (1). Although these cells exert antitumor activity,
they usually fail to control tumor growth due to other factors
such as the presence of regulatory cells and the expression of
inhibitory ligands of the tumor cells. The association between
TILs and a favorable prognosis has been demonstrated in a
few tumors including melanoma and colon cancer (2). 
Likewise, in hepatocellular carcinoma, it is known that
CD8+ TILs may play a role in the occurrence of tumor cell
apoptosis (3), however, CD4+CD25+ regulatory T-cells
impair the effector function of them (4, 5). Although there
are a few reports that describe hepatocellular carcinoma with
lymphoid rich stroma, so called lymphoepithelioma-like
hepatocellular carcinoma (6, 7), the phenotypic analysis of
TILs in 28 cases of hepatocellular carcinoma revealed that
hepatocellular carcinoma tissues had less intensity of lym-
phocyte infiltration than the corresponding non-tumor liver
tissues with increased CD4+CD25+ regulatory T-cells.
Here we report an unusual type of TIL composed of imma-
ture T-cells in a patient with hepatocellular carcinoma. Because
almost TILs in hepatocellular carcinoma are activated type
and expressed antigen-experienced phenotypes (8) this find-
ing is very exceptional and up to now only one similar case
was previously reported. This case further suggests that hep-
atocellular carcinoma could occur in association with indo-
lent T-lymphoblastic proliferation.
CASE REPORT
A 58-yr-old female patient presented with indigestion and
a palpable epigastric mass for two months. The patient was
diagnosed as being a hepatitis B s-antigen (HBsAg) carrier
15 yr previously. However, she received no medical treatment.
The patient had no history of excessive alcohol intake. The
serum alpha-1-fetoprotein measured 17,400 ng/mL. The white
blood cell count was 2,600/mL, and the platelet count was
86,000/mL. The abdominal computed tomography (CT) scan
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Hepatocellular Carcinoma with Immature T-Cell (T-lymphoblastic) 
Proliferation
Indolent T-lymphoblastic proliferation has been rarely reported in the upper aerodi-
gestive tract. The lymphoid cells associated with this condition have the morpho-
logical and phenotypical features of immature thymocytes. However, their patho-
genesis and biology are unknown. We present an unusual type of tumor infiltrating
lymphocytes in a case with hepatocellular carcinoma, presumed to be a T-lym-
phoblastic proliferation. A 58-yr-old female patient presented with indigestion and
a palpable epigastric mass. The abdominal computed tomography revealed a mass
in the S6 region of the liver. A hepatic segmentectomy was performed. Microscop-
ic examination showed dense isolated nests of monomorphic lymphoid cells within
the tumor. Immunohistochemically, the lymphoid cells were positive for CD3, ter-
minal deoxymucleotide transferase (TdT) and CD1a. In addition, they showed dual
expression of CD4 and CD8. The polymerase chain reaction used to examine the
T-cell antigen receptor gamma gene rearrangement showed polyclonal T-cell pro-
liferation. This is the second case of hepatocellular carcinoma combined with indo-
lent T-lymphoblastic proliferation identified by an unusual tumor infiltrating lympho-
cytes.  
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tumor was confined to the liver; the other organs showed no
abnormalities. The patient received hepatic segmentectomy. 
Grossly the tumor measured 5 cm in diameter and had a
multinodular confluent pattern with a yellow-tan color. The
microscopic examination revealed a poorly differentiated hep-
atocellular carcinoma (Edmonson grade 3) with a macrotra-
becular and acinar pattern (Fig. 1A). At the periphery, the
tumor showed poorer differentiation (Edmonson grade 4) and
many giant cells. The surrounding non-neoplastic liver paren-
chyma was replaced by cirrhotic nodules, 3-5 mm in diam-
eter. Notably, there were foci of extensive infiltrations of lym-
phoid cells within the tumor. The lymphoid cells occasion-
ally formed dense isolated nests between the cords of tumor
cells (Fig. 1B). The lymphoid cells were small with a round
nucleus and had scanty cytoplasm. The nucleus was basophilic
with indistinct nucleoli. They showed monomorphic features
with little cytologic atypism (Fig. 1C). On the immunohis-
tochemical staining, the monomorphic lymphoid cells were
positive for CD3 (Fig. 1F), terminal deoxynucleotide trans-
ferase (TdT) (Fig. 1I) and CD1a. They showed dual expres-
sion of CD4 and CD8 (Fig. 1G, H). The above morphologi-
cal and immunohistochemical features of the lymphoid cells
were consistent with the phenotype of immature T-lympho-
blasts. They were all negative for L26 (Fig. 1E), CD79a, gran-
zyme, CD68, CD5, and c-kit. They had a relatively high Ki-
67 labeling index (approximately more than 40%) (Fig. 1D).
The polymerase chain reaction to examine the T-cell antigen
receptor gamma gene rearrangement, revealed polyclonal T-
cell proliferation. 
On the other hand, in the peripheral portion of the tumor,
small numbers of polymorphic TILs composed of mature T
or B lymphocytes or plasma cells were observed. Some of the
polymorphic TILs showed limited infiltration into the por-
tal area and lobules of the hepatic parenchyma around the
tumor. 
Two months later, the patient presented with a chest wall
mass. The radiological examination showed recurrence of
the tumor in the liver with portal vein involvement, multi-
ple lung and rib metastases. Although biopsy was not per-
formed, the CT scan favored the possibility of aggravation
of hepatocellular carcinoma and the serum alpha-1-fetopro-
tein measured 15,000 ng/mL at that time. The operability
of the tumor was very low so the patient is receiving conser-
vative management.
DISCUSSION
The porcine species is known to have a large percentage of
CD4 and CD8 dual expressing peripheral T-cells (9). How-
ever, in humans, CD4 and CD8 dual expressing T-cells can be
found in thymic cortex in which reside the immature thymic
T-lymphocytes, and extrathymic precursor T-cells and T-lym-
phoblastic lymphoma/leukemia. Positivity for TdT is observed
in cortical thymocytes and immature bone marrow T and B
cell precursors undergoing antigen receptor gene rearrange-
ment. The immunophenotype found in the lymphocytes of
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Fig. 1. Histological and immunohistochemical features. (A) The hepatocellular carcinoma is composed of poorly differentiated cells with
trabecular pattern (H&E, ×200). (B) Aggregates of monomorphic lymphoid cells are observed within the hepatocellular carcinoma (H&E,
×100). (C) The lymphocytes show a morphology similar to immature thymocytes (H&E, ×400). (D) Ki67 labeling index is approximately
40% (H&E, ×400). (E) The lymphoid cells are negative for L26 (H&E, ×100). (F) The lymphoid cells are positive for CD3 (H&E, ×100).
(G, H) The lymphoid cells show dual expression of CD4 and CD8 (G, CD4; H, CD8) (H&E, ×100). (I) TdT are expressed in lymphoid cells
(H&E, ×400).the present case was the same as that of precursor (immature)
T-cell or T-lymphoblastic lymphoma/leukemia. In addition,
they showed a high Ki-67 proliferation index, which made
us to considered the possibility of neoplastic precursor T cell
proliferation. 
T-lymphoblastic lymphoma/leukemia is a high-grade neo-
plasm composed of small to medium sized blastic cells. Pati-
ents with T-lymphoblastic lymphoma/leukemia frequently
present with a mediastinal mass and rapidly progressive dis-
ease if untreated. In our case, the proliferating lymphocytes
were morphologically and immunohistochemically T lym-
phoblasts. However, the presentation was apart from the usual
T-lymphoblastic lymphoma. In addition, the polymerase chain
reaction study did not show monoclonal T-cell proliferation.
Therefore, the possibility of T-lymphoblastic lymphoma/
leukemia was excluded. 
The liver plays an important role in innate and adaptive
immunity through the production of acute phase proteins,
phagocytosis and removal of activated T-cells (11). Extra-
thymic T-cell development and proliferation also could be
occur in the mammalian liver, and this function becomes
more important with aging (10-12). Therefore, the hepatic
T-cell population is quite different from those of other organs.
For example, unlike the peripheral blood, the conventional
CD4+or CD8+T-cells account only 40% of hepatic CD3+
T-cells. However, CD4+CD8+ dual expressing T-cells and
CD4-CD8- dual negative T-cells account for a significant
proportion of hepatic T-cells (13). IL-7 induced proliferation
of T-cells with intermediate levels of TCR and CD4/CD8 dual
negative or CD4 positive phenotype in the murine liver (14).
In the human liver, the hepatic microenvironment including
cytokines might influence the distribution of T-cell popula-
tions, and increased production of certain cytokines might
result in selective expansion of the resident population of T-
cells under pathological conditions. In the present case, it
would be possible that certain cytokines produced by trans-
formed hepatocytes of hepatocellular carcinoma, might have
stimulated the expansion of resident CD4+CD8+ dual ex-
pressing immature T-cells, or recruited them from the thymic
cortex or bone marrow. 
Wang et al. previously reported one similar case. They pre-
sented a case with hepatocellular carcinoma accompanied by
TdT positive T lymphocyte proliferation in the tumor. They
suggested that their patient had indolent T-lymphoblastic
proliferation combined with hepatocellular carcinoma (15).
Indolent T-lymphoblastic proliferation was first described by
Velankar et al. in 1999 in the upper aerodigestive tract (16).
Two years later Strauchen reported a similar phenomenon in
the oropharynx in a myasthenia gravis patient (17). In this
newly introduced disorder, the infiltrating lymphocytes show-
ed lymphoblastic morphology and expressed TdT, and both
CD4 and CD8. Although the two patients suffered from mul-
tiple recurrences over a long time, they showed no systemic
dissemination with or without chemotherapy. Whether this
disorder is a neoplastic proliferation or true hyperplasia of T-
lymphoblasts remains unclear. Strauchen reported that the tro-
pism of the T-lymphoblasts of the oropharynx due to retained
thymic potential of the pharyngeal epithelium might cause
the indolent T-lymphoblastic proliferation (17). Wang sug-
gested that hepatocellular carcinoma could recruit immature
T-lymphocytes into the tumor from the thymic cortex or bone
marrow through unknown mechanisms (15). 
The clinical course of the present case was more aggressive
than that of Wang’s case and showed multiple metastases
two months after the initial diagnosis and treatment. If the
immature T-cell proliferation accompanying the hepatocel-
lular carcinoma was related to a poor patient prognosis should
be clarified by further study. 
In conclusion, we have reported a second case of hepato-
cellular carcinoma with T-cell lymphoblastic proliferation
as a type of unusual TIL. The precise mechanism of the T
lymphoblastic proliferation in the hepatocellular carcinoma
and the clinicopathological significance require further elu-
cidation. 
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